Navigation Links
The WFH receives the largest humanitarian aid donation in its history - Donation represents more than 40 million international units to the WFH
Date:12/2/2009

MONTREAL, Dec. 2 /PRNewswire/ - As part of its continued commitment to hemophilia care around the world, Wyeth, now a part of Pfizer, has pledged more than 40 million international units (IUs) of factor concentrates to the World Federation of Hemophilia (WFH). This is the largest donation ever made to the WFH's Humanitarian Aid Program, and will make a significant impact to advance the WFH's goals.

"This donation will directly support building sustainable national care programs for people with bleeding disorders," said Mark Skinner, WFH president. "We are very proud to work with Wyeth, which has historically been the largest single donor of hemophilia products to the WFH."

The donation will bring life-saving treatment to many people with hemophilia around the world who would not otherwise have access to adequate treatment. Notably, participants of the WFH Twinning Program will receive some of the donated product which will help improve their quality of life. It will also support adults and young children who have no access to treatment and patients with life-threatening bleeding episodes.

"We are committed to working with partner organizations to provide access to hemophilia medicines to patients who need them," said Geno Germano, president and general manager of the Specialty Care Business Unit at Pfizer.

This donation and Wyeth's ongoing commitment will continue to strengthen the WFH's Humanitarian Aid program and will help provide those in need with valuable and life-saving medicines.

About hemophilia and other bleeding disorders

One in 5,000 boys is born with hemophilia. This means that their blood does not clot properly and this can often be fatal due to internal bleeding. However, with proper care and management, patients with hemophilia and bleeding disorders can lead a longer, healthier life.

Hemophilia, von Willebrand disease, and other factor deficiencies are lifelong bleeding disorders that prevent blood from clotting properly. People with bleeding disorders do not have enough of a particular clotting factor, a protein in blood that controls bleeding, or it does not work properly. The severity of a person's bleeding disorder usually depends on the amount of clotting factor that is missing or not working. People with hemophilia can experience uncontrolled internal bleeding that can result from a seemingly minor injury. Bleeding into joints and muscles causes severe pain and disability. Bleeding into major organs, such as the brain, can cause death.

About the World Federation of Hemophilia (WFH)

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and related bleeding disorders. Established in 1963, it is a global network of patient organizations in 113 countries and has official recognition from the World Health Organization. Visit WFH online at www.wfh.org.

SOURCE World Federation of Hemophilia


'/>"/>
SOURCE World Federation of Hemophilia
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... April 28, 2016 , ... ... Surgery Education and Anzu®, developers of the AnzuMedical™ Knowledge Sharing and Collaboration ... Collaborative Residency Network. The platform is scheduled to launch in July 2016 and ...
(Date:4/28/2016)... , ... April 28, 2016 , ... ... has been named a Top Doc in Physical Medicine and Rehabilitation by Philadelphia ... Castle Connolly Medical, Ltd. by randomly surveying physicians and medical leadership across the ...
(Date:4/28/2016)... ... 2016 , ... Starting today, households across the United States ... Prescription Assistance Program. They are customized to reflect the specific health needs of ... ready-to-use, state-themed card and, in the near future, material that highlights savings on ...
(Date:4/28/2016)... ... , ... North Hollywood dentist , Dr. Hamid Reza, now offers emergency ... comes to dental accidents or critical dental problems. These issues can threaten a person's ... knocked-out teeth, chipped teeth, and many other issues can lead to emergency situations, and ...
(Date:4/28/2016)... California (PRWEB) , ... April 28, 2016 , ... For many, a diet is only ... crave it if it does not look good. In addition, an individual cannot deny the ... well. , The team, therefore, has worked to create a product range that could ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016 , Net Sales of $1.90 billion ... the prior year period, and an increase of 1.2% on ... EPS for the first quarter were $0.52 reported, a decrease ... an increase of 29.9% over the prior year period ... guidance for 2016 Zimmer Biomet Holdings, Inc. (NYSE ...
(Date:4/28/2016)... , April 28, 2016 TapImmune,Inc. ... of innovative peptide and gene-based immunotherapeutics and vaccines for the ... be presenting at the 3rd Annual Growth Capital Expo ... th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... on Wednesday, May 4 th by Dr. John ...
(Date:4/27/2016)... --   , Total Sales ... Sales  Clinical sales grow 16% year-over-year  , ... OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser ... quarter ended March 31, 2016 and provided an update ... strategy. First Quarter 2016 Revenue Results by ...
Breaking Medicine Technology: